A computational toxicology investigation evaluating the widely applied organophosphorus insecticide dimethoate indicates that its breakdown metabolites exhibit markedly stronger binding affinities to critical human neuro-enzymes and distinct toxicokinetic profiles compared to the parent active compound. Dimethoate has functioned as a broad-spectrum systemic insecticide and acaricide across agricultural crops and ornamental plants since 1956, exerting insecticidal activity through the inhibition of acetylcholinesterase within the central and peripheral nervous systems. While regulatory assessments have historically centered on the parent chemical structure, researchers employed an integrated in silico framework encompassing Generalized Read-Across, predictive membrane permeation modeling, protein interaction mapping, and molecular docking to systematically contrast dimethoate against twenty-four analogous chemical substances and primary degradation products.
To establish a rigorous comparative dataset, the investigators interrogated chemical repositories including the PubChem database, the United States Environmental Protection Agency Toxicity Reference Database, and the CompTox Chemicals Dashboard. Structural analogy was quantified using Morgan fingerprinting and the Jaccard similarity index, which evaluates molecular feature overlap on a scale ranging from zero for completely dissimilar structures to one for identical features. Initial screening of organophosphate pesticides in ToxRefDB identified phosmet and methidathion as the nearest pesticide analogues to dimethoate, each exhibiting a Jaccard similarity coefficient of 0.28, followed by malathion at 0.26, azinphos-methyl at 0.25, and acephate at 0.24, with propetamphos displaying the lowest similarity at 0.20. Subsequent category expansion incorporating chemical breakdown products identified O-Ethyl O-methyl S-[2-(methylamino)-2-oxoethyl] phosphorodithioate alongside key transformation metabolites including omethoate, des-O-methyldimethoate, and de-N-methyldimethoate.
Toxicokinetic permeability was evaluated using the Brain Or IntestinaL EstimateD permeation model within the SwissADME platform, which resolves compound behavior across the human gastrointestinal tract and the blood-brain barrier through lipophilicity calculated via the Wildman and Crippen log P method alongside the topological polar surface area. In a screening of forty organophosphate insecticides, only three compounds—dichlorvos, heptenophos, and dimethylvinphos—mapped to the yolk region of the BOILED-Egg plot, indicating an ability to passively permeate the blood-brain barrier. Conversely, thirty-four insecticides including dimethoate mapped exclusively to the white albumin region denoting intestinal absorption, while four compounds including ethion, methidathion, malathion, and phosalone fell within the outer grey area corresponding to both poor blood-brain barrier penetration and impaired intestinal absorption.
When assessing the fourteen analogues demonstrating higher structural similarity to dimethoate, every chemical mapped directly to the white albumin sector of the BOILED-Egg diagram, indicating favorable human intestinal absorption following oral intake but an absence of passive transcellular permeability across the blood-brain barrier. Analysis of the ten less similar analogues demonstrated identical patterns, with nine chemicals exhibiting high intestinal absorption while ethion was restricted to the non-permeant grey territory. Several less similar compounds, such as methyl carbamate, methomyl, monocrotophos, acephate, and propetamphos, exhibited higher relative gastrointestinal absorption capacity than dimethoate. The main active metabolite, omethoate, likewise demonstrated greater intestinal absorption capacity than the parent compound, supporting expectations of rapid systemic uptake after ingestion.
The researchers noted that the computational prediction of limited passive blood-brain barrier permeation stands in sharp contrast to established in vivo clinical observations and animal toxicology studies, which repeatedly demonstrate that dimethoate and its oxygenated metabolite omethoate induce pronounced central nervous system neurotoxicity. This observed divergence underscores a fundamental mechanistic limitation of passive in silico diffusion algorithms. The BOILED-Egg model computes transit solely on physical lipophilicity and polar surface parameters, thereby omitting active carrier-mediated transport across the cerebral microvascular endothelium and failing to account for potential chemical disruption of tight junction physical barriers under acute poisoning conditions. The authors highlighted that direct passive diffusion into the central nervous system appears restricted, pointing toward peripheral nervous system targets or alternative active transport mechanisms as drivers of central accumulation.
Evaluation of dermal penetration coefficients revealed that all twenty-four screened chemical analogues exhibit low passive skin permeability. Based on established pharmacokinetic thresholds where a log Kp value exceeding negative 2.5 centimeters per second indicates relatively high skin permeability, every tested analogue fell substantially below this cutoff. Dimethoate exhibited a log Kp value of -7.14, whereas its active metabolite omethoate showed an even lower dermal permeability coefficient of -8.13. Other metabolites, such as de-N-methyldimethoate and des-O-methyldimethoate, yielded log Kp values of -7.34 and -7.83 respectively, while S-{2-[(methoxymethyl)amino]-2-oxoethyl} O,O-dimethyl phosphorodithioate registered at -7.36. All screened compounds yielded an identical bioavailability score of 0.55, confirming compliance with basic structural criteria under Lipinski rules of five.
To explore macromolecular engagement, chemical-protein interaction networks were mapped through the STITCH version 5.0 database using a confidence Z-score threshold exceeding 0.5 for Homo sapiens targets. The network topology identified that butyrylcholinesterase interacted with sixteen percent of the screened chemicals, including dimethoate, phosphorothioate, omethoate, methidathion, malathion, azinphos-methyl, acephate, monocrotophos, and methomyl. Acetylcholinesterase interacted with twelve percent of compounds, whereas patatin-like phospholipase domain-containing protein 6—also known as neuropathy target esterase—interacted with dimethoate, phosphorodithioate, and acephate. Estrogen receptor 1 was targeted by six percent of chemicals including dimethoate, malathion, and ethion, while the antioxidant enzyme catalase was predicted to interact with four percent of compounds, specifically dimethoate and malathion.
Targeted molecular docking calculations conducted via Vina Wizard in PyRx across fifty independent iterations per complex revealed marked disparities in binding energetics between parent chemicals and their degradation products. The endogenous neurotransmitter acetylcholine provided an established literature baseline affinity of negative 4.1 kilocalories per mole with acetylcholinesterase. Dimethoate registered a binding energy of -5.5 kilocalories per mole, whereas its primary active metabolite omethoate exhibited a stronger affinity of -5.6 kilocalories per mole, confirming enhanced competitive potential against native substrates. Omethoate consistently displayed the strongest binding affinities across all evaluated macromolecules, achieving an interaction energy of -6.0 kilocalories per mole with the isolated D-subunit heme pocket of catalase. The metabolites des-O-methyldimethoate and de-N-methyldimethoate similarly demonstrated binding energies exceeding or closely approximating parent dimethoate across acetylcholinesterase, butyrylcholinesterase, patatin-like phospholipase domain-containing protein 6, catalase, and estrogen receptor 1.
Statistical evaluation incorporating correlation analyses in PAST software demonstrated that physicochemical properties within Lipinski criteria did not correlate significantly with computed protein binding affinities. Two-way analysis of variance in GraphPad Prism, based on conformational variance across the fifty independent computational docking runs, indicated statistically significant differences in binding affinities between parent dimethoate, non-pesticidal structural analogues, and primary metabolites. Non-pesticidal structural analogues with higher Jaccard similarity indices, such as O-Ethyl O-methyl S-[2-(methylamino)-2-oxoethyl] phosphorodithioate and O,O-Dimethyl S-{2-[methyl(2H)amino]-2-oxoethyl} phosphorodithioate, demonstrated lower binding affinities for target proteins than the active metabolites, confirming that structural similarity metrics alone do not reliably reflect biological potencies.
The study authors emphasized several critical methodological limitations inherent to computational modeling. Molecular docking relies on rigid receptor conformations, representing static snapshots that omit solvent dynamics, entropic contributions, and real-time conformational fluctuations. Structural models for patatin-like phospholipase domain-containing protein 6 relied on AlphaFold predictions rather than crystallographically resolved human coordinates, and docking protocols lacked re-docking root-mean-square deviation validation against co-crystallized ligands. The researchers concluded that extensive molecular dynamics simulations, free energy calculations, and empirical wet-lab validation using human cell lines or organ-on-a-chip platforms remain essential to corroborate these predictive findings and ensure comprehensive safety regulation of organophosphorus degradation products.
To quantify historical scientific attention surrounding degradation products, the investigators conducted a bibliometric analysis across the Dimensions platform using VOSviewer visualization software. This literature assessment identified only 53 publications published between 1990 and 2025 regarding the toxic effects of dimethoate analogues, revealing that omethoate was the only metabolite to receive dedicated investigation. The authors noted that while regulatory agencies including the European Food Safety Authority and the United States Environmental Protection Agency have restricted or prohibited specific structural analogues, multiple related insecticides remain widely applied in global agriculture, where prior human testing estimated dermal permeation for parent dimethoate at 14.75 percent.
To uncover systemic biological disruptions, the researchers supplemented primary docking with Gene Ontology categorizations and Kyoto Encyclopedia of Genes and Genomes pathway evaluations in Homo sapiens. The interactome highlighted that beyond core cholinesterase suppression, the chemicals engaged cytochrome P450 enzymes, specifically CYP2B6 and CYP2E1, while protein-protein linkages connected acetylcholinesterase directly to catalase and patatin-like phospholipase domain-containing protein 6. These multi-protein assemblies initiate signaling cascades implicated in endocrine disruption, oxidative stress regulation, and immune system alterations, illustrating how organophosphate exposures propagate downstream cellular pathology through broader macromolecular networks.
Computational preparation protocols followed rigorous biophysical parameters to standardize docking predictions across macromolecular targets. Protein coordinates obtained from the Protein Data Bank—comprising acetylcholinesterase under accession 1B41, butyrylcholinesterase under 7AIY, catalase under 7DV9, and estrogen receptor 1 under 6VPF—were refined by removing solvent molecules, adding polar hydrogens across a pH range of 6.5 to 8.1, and assigning Kollman-United and Gasteiger charges. Ligand structures underwent universal force field optimization in Open Babel using conjugate gradients across 400 steps. In catalase modeling, the computational workflow isolated a single monomer because all four subunits in the functional homo-tetramer possess structurally identical functional pockets, establishing a reproducible structural baseline across all complexes.
Subject of Research: In silico toxicokinetic and macromolecular docking evaluation of dimethoate and its analogous chemical compounds
Article Title: Comparative toxicity of dimethoate insecticide and analogous compounds in humans
Article References: Sadhu, A., Mandal, A. H., Ghosh, S., Roy, T., Dey, S., Saha, N. C., Biswas, J. K., & Saha, S. (2026). Comparative toxicity of dimethoate insecticide and analogous compounds in humans. Discover Toxicology, 3(1), Article 22. https://doi.org/10.1007/s44339-026-00068-8
Image Credits: AI Generated
DOI: 10.1007/s44339-026-00068-8
Keywords: dimethoate, omethoate, toxicokinetics, acetylcholinesterase, butyrylcholinesterase, organophosphates, BOILED-Egg model, blood-brain barrier, intestinal absorption, skin permeability, molecular docking, computational toxicology, Generalized Read-Across, catalase, PNPLA6, pesticide metabolites
News Source: Violet Maxwell. (November 20, 2026). Dimethoate Metabolites Pose Greater Predicted Toxicological Risks Than Parent Insecticide. Scienmag.



